Irreversible electroporation of the pancreas: Definitive local therapy without systemic effects

Journal of Surgical Oncology

Volumn 104, Issue 1, 2011, Pages 22-28

  Bower, Matthew ^a   Sherwood, Leslie ^b   Li, Yan ^a   Martin, Robert ^a  

^a UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

Ablation; Cancer; Irreversible electroporation; Pancreas

Indexed keywords

AMYLASE; TRIACYLGLYCEROL LIPASE;

ABLATION THERAPY; ADHESION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASCITES; CONTROLLED STUDY; ELECTRIC POTENTIAL; ELECTROPORATION; LOCAL THERAPY; NONHUMAN; PANCREAS; PANCREAS NECROSIS; PANCREATITIS; PRIORITY JOURNAL; SAFETY; SWINE; ULTRASOUND;

AMYLASES; ANIMALS; CATHETER ABLATION; ELECTROPORATION; FEMALE; LIPASE; MODELS, ANIMAL; PANCREAS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; SUS SCROFA; TREATMENT OUTCOME;

EID: 79958091355     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21899     Document Type: Article

References (27)

1. Patterson EJ, Scudamore CH, Owen DA, et al.: Radiofrequency ablation of porcine liver in vivo: Effects of blood flow and treatment time on lesion size. Ann Surg 1998;227:559-565. (Pubitemid 28363274)
2. Date RS, McMahon RF, Siriwardena AK: Radiofrequency ablation of the pancreas. I: Definition of optimal thermal kineticparameters and the effect of simulated portal venous circulation in an ex-vivo porcine model. JOP 2005;6:581-587. (Pubitemid 41671976)
3. Granot Y, Rubinsky B: Mass transfer model for drug delivery in tissue cells with reversible electroporation. Int J Heat Mass Transf 2008;51:5610-5616.
4. Escobar-Chavez JJ, Bonilla-Martinez D, Villegas-Gonzalez MA, et al.: Electroporation as an efficient physical enhancer for skin drug delivery. J Clin Pharmacol 2009;49:1262-1283.
5. Prud'homme GJ, Glinka Y, Khan AS, et al.: Electroporation-enhanced nonviral gene transfer for the prevention or treatment of immunological, endocrine and neoplastic diseases. Curr Gene Ther 2006;6:243-273.
6. Andre FM, Gehl J, Sersa G, et al.: Efficiency of high- and low-voltage pulse combinations for gene electrotransfer in muscle, liver, tumor, and skin. Hum Gene Ther 2008;19:1261-1271.
7. Lee RC: Cell injury by electric forces. Ann N Y Acad Sci 2005; 1066:85-91.
8. Davalos RV, Mir IL, Rubinsky B: Tissue ablation with irreversible electroporation. Ann Biomed Eng 2005;33:223-231. (Pubitemid 40496051)
9. Rubinsky B, Onik G, Mikus P: Irreversible electroporation: A new ablation modality - clinical implications. Technol Cancer Res Treat 2007;6:37-48. (Pubitemid 46389347)
10. Edd JF, Horowitz L, Davalos RV, et al.: In vivo results of a new focal tissue ablation technique: Irreversible electroporation. IEEE Trans Biomed Eng 2006;53:1409-1415. (Pubitemid 44172315)
11. Maor E, Ivorra A, Leor J, et al.: The effect of irreversible electroporation on blood vessels. Technol Cancer Res Treat 2007;6: 307-312. (Pubitemid 47340123)
12. Al-Sakere B, Andre F, Bernat C, et al.: Tumor ablation with irreversible electroporation. PLoS One 2007;2:e1135.
13. Onik G, Mikus P, Rubinsky B: Irreversible electroporation: Implications for prostate ablation. Technol Cancer Res Treat 2007;6:295-300. (Pubitemid 47340121)
14. Garcia PA, Rossmeisl JH Jr., Robertson J, et al.: Pilot study of irreversible electroporation for intracranial surgery. Conf Proc IEEE Eng Med Biol Soc 2009;2009:6513-6516.
15. Rubinsky J, Onik G, Mikus P, et al.: Optimal parameters for the destruction of prostate cancer using irreversible electroporation. J Urol 2008;180:2668-2674.
16. Mir LM: Therapeutic perspectives of in vivo cell electropermeabilization. Bioelectrochemistry 2001;53:1-10.
17. Neal RE, Davalos RV: The feasibility of irreversible electroporation for the treatment of breast cancer and other heterogeneous systems. Ann Biomed Eng 2009;37:2615-2625.
18. Daniels C, Rubinsky B: Electrical field and temperature model of nonthermal irreversible electroporation in heterogeneous tissues. J Biomech Eng 2009;131:071006.
19. Edd JF, Davalos RV: Mathematical modeling of irreversible electroporation for treatment planning. Technol Cancer Res Treat 2007;6:275-286. (Pubitemid 47340119)
20. Lee EW, Loh CT, Kee ST: Imaging guided percutaneous irreversible electroporation: Ultrasound and immunohistological correlation. Technol Cancer Res Treat 2007;6:287-294.
21. Granot Y, Ivorra A, Maor E, et al.: In vivo imaging of irreversible electroporation by means of electrical impedance tomography. Phys Med Biol 2009;54:4927-4943.
22. Goldberg SN, Mallery S, Gazelle GS, et al.: EUS-guided radiofrequency ablation in the pancreas: Results in a porcine model. Gastrointest Endosc 1999;50:392-401. (Pubitemid 29418828)
23. Di MF, Martino M, Rea R, et al.: EUS-guided Nd:YAG laser ablation of normal pancreatic tissue: A pilot study in a pig model. Gastrointest Endosc 2010;72:358-363.
24. Matthes K, Mino-Kenudson M, Sahani DV, et al.: Concentration- dependent ablation of pancreatic tissue by EUS-guided ethanol injection. Gastrointest Endosc 2007;65:272-277. (Pubitemid 46157119)
25. Sugito K, Kusafuka T, Hoshino M, et al.: Application of radiofrequency ablation for giant solid pseudopapillary tumor of the pancreas. Pediatr Int 2010;52:e29-e31.
26. Date RS, Siriwardena AK: Radiofrequency ablation of the pancreas. II: Intra-operative ablation of non-resectable pancreatic cancer. A description of technique and initial outcome. JOP 2005;6:588-592. (Pubitemid 41671977)
27. Date RS, Biggins J, Paterson I, et al.: Development and validation of an experimental model for the assessment of radiofrequency ablation of pancreatic parenchyma. Pancreas 2005;30: 266-271. (Pubitemid 40397380)